Accelerated Disease Progression after Discontinuation of Sorafenib in a Patient with Metastatic Papillary Thyroid Cancer

Distant metastases from papillary thyroid carcinoma (PTC) are rare and are associated with a poor prognosis. Here, we describe a patient with metastatic PTC who was treated with a tyrosine kinase inhibitor (TKI, sorafenib) for several months that was acutely exacerbated by discontinuation. A 43-year...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Yun, Kyung-Jin, Kim, Woohyeon, Kim, Eun Hee, Kim, Min-Hee, Lim, Dong-Jun, Kang, Moo-Il, Cha, Bong-Yun
التنسيق: Artigo
اللغة:Inglês
منشور في: Korean Endocrine Society 2014
الموضوعات:
Case Report
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4192805/
https://ncbi.nlm.nih.gov/pubmed/25309799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2014.29.3.388
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة